Anna Cassano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna Cassano has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Cristina Scoditti
Institute of Pulmonary Disease, University of Bari, Bari, Italy
1 shared publication - Donato Lacedonia
Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy
1 shared publication - Ester Boniello
Institute of Pulmonary Disease, University of Bari, Bari, Italy
1 shared publication - Felice Gadaleta
Institute of Pulmonary Disease, University of Bari, Bari, Italy
1 shared publication - Giuseppe Di Maria
Institute of Pulmonary Disease, University of Catania, Catania, Italy
1 shared publication - Lucia Spicuzza
Institute of Pulmonary Disease, University of Catania, Catania, Italy
1 shared publication
Latest Publications
- Open Access
- 10 March 2009
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 4 (1) , 10
Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease, which rapidly leads to chronic respiratory failure requiring mechanical ventilation. Currently, forced vital capacity (FVC) < 50% is considered as physiologic marker for admitting patients to Noninvasive Positive Pressure Ventilation (NPPV) intervention, although it has been recently shown the median survival of patients with baseline FVC < 75% much shorter than median survival of patients with baseline FVC > 75%, independently by any treatment.
- 10 March 2009
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 4 (1) , 10
Open AccessEarly treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease, which rapidly leads to chronic respiratory failure requiring mechanical ventilation. Currently, forced vital capacity (FVC) < 50% is considered as physiologic marker for admitting patients to Noninvasive Positive Pressure Ventilation (NPPV) intervention, although it has been recently shown the median survival of patients with baseline FVC < 75% much shorter than median survival of patients with baseline FVC > 75%, independently by any treatment.